Literature DB >> 3140971

Suppression of ovulation by transdermal oestradiol patches.

N R Watson1, J W Studd, A F Riddle, M Savvas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140971      PMCID: PMC1834440          DOI: 10.1136/bmj.297.6653.900

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Biologic effects of transdermal estradiol.

Authors:  R J Chetkowski; D R Meldrum; K A Steingold; D Randle; J K Lu; P Eggena; J M Hershman; N K Alkjaersig; A P Fletcher; H L Judd
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

2.  Effects of subcutaneous oestradiol implants on ovarian activity.

Authors:  A L Magos; W P Collins; J W Studd
Journal:  Br J Obstet Gynaecol       Date:  1987-12

3.  Implantation of pure crystalline pellets of estradiol for conception control.

Authors:  R B Greenblatt; R H Asch; V B Mahesh; J R Bryner
Journal:  Am J Obstet Gynecol       Date:  1977-03-01       Impact factor: 8.661

  3 in total
  3 in total

1.  Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.

Authors:  Jennifer L Gordon; David R Rubinow; Tory A Eisenlohr-Moul; Kai Xia; Peter J Schmidt; Susan S Girdler
Journal:  JAMA Psychiatry       Date:  2018-02-01       Impact factor: 21.596

Review 2.  Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.

Authors:  J A Balfour; R C Heel
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of contraceptive steroids. An update.

Authors:  G M Shenfield; J M Griffin
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.